Friday, December 01, 2023
Outlook India
Outlook Business

Signet Healthcare Partners invests in healthcare start-up LAXAI

The integrated provider of drug discovery, development and manufacturing services plans to leverage Signet's pharma services expertise for business growth

Signet Healthcare Partners invests in healthcare start-up LAXAI

Outlook Start-Up Desk

POSTED ON October 25, 2022 6:14 PM

LAXAI Inc has received a growth capital investment from Signet Healthcare Partners, a New York-based healthcare private equity firm. The Hyderabad-based start-up claimed that this equity investment would provide it with a long-term, well-capitalised financial partner to support its growth strategy.

The terms of the transaction were not disclosed.

LAXAI is an integrated contract research, development and manufacturing organisation that delivers solutions in drug discovery, chemical process R&D and generic mapping manufacturing for pharmaceutical, biotech and speciality chemicals companies globally. It operates a drug substance manufacturing facility and innovation centre in Hyderabad and has offices in the US. 

LAXAI will utilise a substantial portion of Signet's investment to enhance its capabilities and establish its technical operations in the US. The company's chairman and managing director Vamsi Maddipatla, said, "Signet's investment will enhance our infrastructure and further augment operations to help our customers and partners maximise innovation and productivity."

New York-based Signet has raised funds with total capital commitments of over $500 million and has invested in more than 55 companies. Its managing director Nikhil Puri added, "Pharmaceutical outsourcing has become mission-critical within drug development. Our investment in LAXAI is an attractive opportunity to partner with another contract research and development and manufacturing organisation."

  • Related Articles

    Last Wednesday, the watchdog slapped penalties totalling Rs 392 crore on MakeMyTrip, Goibibo and OYO for unfair business practices

    CCI addressing competition concerns in digital markets through anti-trust enforcement measures: Chairperson

    The artificial intelligence start-up creates natural language processing that software developers can use to build business applications

    Google in talks to invest $200 million in Cohere

    The global investment firm joins UPL as an investor in the farming solutions start-up Tags: KKR, UPL, Jai Shroff, Advanta, agritech

    KKR to invest $300 million in Advanta Enterprises for 13.33 per cent stake